Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. NOW
3. DHR
4. USO
5. NVDA
6. SPY
7. AMD
8. TSLA
9. GM
10. SMCI

Go back to Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy
ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 2,036       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 2,036       

Daiichi Sankyo Co Limited Sponsored ADR (AMEX: DSNKY) Delayed: 17.06 --0 (-0%)
Previous Close $17.06    52 Week High $26.24 
Open $17.06    52 Week Low $18.86 
Day High $17.06    P/E N/A 
Day Low $17.06    EPS $0.00 
Volume 595